Study Reference No. - C2D01384
| Demographic | Gender | Age | Location | Compensation |
|---|---|---|---|---|
| History of allergy to ragweed for at least the last 2 years | Males and Females | At least 18 years | Mississauga, ON | $2,800 |
Study Details |
|
Study Purpose |
The primary purpose of this study is to find out if the Test product, Reproxalap Ophthalmic Solution (0.25%), is safe and effective to treat allergic conjunctivitis in comparison to the Vehicle Ophthalmic Solution, when study participants are exposed to airborne ragweed pollen in the Environmental Exposure Chamber (EEC). |
Study Duration |
Approximately 4 visits that includes Medical Screening (Visit 1), Screening in EEC (Visit 2), and 2 Study Treatments in EEC (Visit 3 and 4). |
Study Schedule |
|
General Screening |
NA |
Medical Screening |
Multiple dates. Contact recruitment. |
Study Visit(s) |
Multiple cohorts/dates. Contact recruitment. |
Follow-Up Visit(s) |
N/A |
Other Notes |
|
Bring Valid Photo ID. |
|
COVID-19 test will be conducted prior to designated visits. |
|